| Product Code: ETC6174139 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Apixaban Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Apixaban Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Apixaban Market - Industry Life Cycle |
3.4 Australia Apixaban Market - Porter's Five Forces |
3.5 Australia Apixaban Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.6 Australia Apixaban Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.7 Australia Apixaban Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Apixaban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases leading to higher demand for anticoagulant medications like apixaban in Australia. |
4.2.2 Rising awareness among healthcare professionals and patients about the benefits and efficacy of apixaban compared to traditional anticoagulants. |
4.2.3 Growing geriatric population in Australia, who are more prone to conditions requiring anticoagulant therapy. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for new medications like apixaban in Australia. |
4.3.2 Competition from existing anticoagulant drugs and potential entry of new alternatives in the market. |
5 Australia Apixaban Market Trends |
6 Australia Apixaban Market, By Types |
6.1 Australia Apixaban Market, By Dosage Form |
6.1.1 Overview and Analysis |
6.1.2 Australia Apixaban Market Revenues & Volume, By Dosage Form, 2021- 2031F |
6.1.3 Australia Apixaban Market Revenues & Volume, By Capsule, 2021- 2031F |
6.1.4 Australia Apixaban Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2 Australia Apixaban Market, By End-Users |
6.2.1 Overview and Analysis |
6.2.2 Australia Apixaban Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Australia Apixaban Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 Australia Apixaban Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 Australia Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Apixaban Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Apixaban Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Australia Apixaban Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Australia Apixaban Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.5 Australia Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Apixaban Market Import-Export Trade Statistics |
7.1 Australia Apixaban Market Export to Major Countries |
7.2 Australia Apixaban Market Imports from Major Countries |
8 Australia Apixaban Market Key Performance Indicators |
8.1 Number of prescriptions for apixaban filled in Australia. |
8.2 Patient adherence rates to apixaban treatment regimens. |
8.3 Number of clinical trials and studies conducted on apixaban in Australia. |
8.4 Rate of adverse events or side effects reported for apixaban use in Australia. |
8.5 Level of insurance coverage and reimbursement policies for apixaban in Australia. |
9 Australia Apixaban Market - Opportunity Assessment |
9.1 Australia Apixaban Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.2 Australia Apixaban Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.3 Australia Apixaban Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Apixaban Market - Competitive Landscape |
10.1 Australia Apixaban Market Revenue Share, By Companies, 2024 |
10.2 Australia Apixaban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |